{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T15:24:09Z","timestamp":1778081049854,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.imbio.2023.152348","type":"journal-article","created":{"date-parts":[[2023,2,11]],"date-time":"2023-02-11T10:50:24Z","timestamp":1676112624000},"page":"152348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Study of some immunological signatures and their association with COVID-19 in a sample of recovered Iraqi patients"],"prefix":"10.1016","volume":"228","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8975-6063","authenticated-orcid":false,"given":"Fadia M.","family":"Maki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amina N.","family":"AL-Thwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem S.","family":"Jiad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.imbio.2023.152348_b0005","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/infdis\/jiac017","article-title":"Persistent autoimmune activation and proinflammatory state in post-coronavirus disease 2019 syndrome","volume":"225","author":"Acosta-Ampudia","year":"2022","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.imbio.2023.152348_b0015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmi.2021.11.002","article-title":"Female sex is associated with long COVID syndrome: a prospective cohort study","volume":"28","author":"Bai","year":"2022","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.imbio.2023.152348_b0020","article-title":"Chronic COVID syndrome: Need for an appropriate medical terminology for long-COVID and COVID long-haulers","author":"Baig","year":"2020","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.imbio.2023.152348_b0025","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.3390\/jcm9103188","article-title":"Persistence of anti-SARS-CoV-2 antibodies in non-hospitalized COVID-19 convalescent health care workers","volume":"9","author":"Bruni","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.imbio.2023.152348_b0030","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/jmv.25681","article-title":"Emerging coronaviruses: genome structure, replication, and pathogenesis","volume":"92","author":"Chen","year":"2020","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152348_b0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.imbio.2023.152348_b0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","article-title":"SARS-CoV-2 infection: The role of cytokines in COVID-19 disease","volume":"54","author":"Costela-Ruiz","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"issue":"7851","key":"10.1016\/j.imbio.2023.152348_b0050","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","article-title":"Evolution of antibody immunity to SARS-CoV-2","volume":"591","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2023.152348_b0060","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3389\/fneur.2020.00956","article-title":"COVID-19-related anosmia: the olfactory pathway hypothesis and early intervention","volume":"11","author":"Gori","year":"2020","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.imbio.2023.152348_b0065","doi-asserted-by":"crossref","first-page":"e1136","DOI":"10.1002\/cti2.1136","article-title":"Detection of IgM and IgG antibodies in patients with coronavirus disease 2019","volume":"9","author":"Hou","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.imbio.2023.152348_b0070","doi-asserted-by":"crossref","first-page":"101409","DOI":"10.1016\/j.genrep.2021.101409","article-title":"Comparative study of SARS-CoV-2 antibody titers between male and female COVID-19 patients living in Kurdistan region of Iraq","volume":"25","author":"Ishaq","year":"2021","journal-title":"Gene Reports"},{"issue":"5","key":"10.1016\/j.imbio.2023.152348_b0075","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.it.2020.03.007","article-title":"Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses","volume":"41","author":"Jiang","year":"2020","journal-title":"Trends Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2023.152348_b0080","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/ciab376","article-title":"Differential cytokine signatures of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza infection highlight key differences in pathobiology","volume":"74","author":"Karaba","year":"2022","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.imbio.2023.152348_b0085","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s12276-021-00592-0","article-title":"Type I and III interferon responses in SARS-CoV-2 infection","volume":"53","author":"Kim","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.imbio.2023.152348_b0090","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1080\/22221751.2020.1773324","article-title":"Patterns of IgG and IgM antibody response in COVID-19 patients","volume":"9","author":"Liu","year":"2020","journal-title":"Emerging Microbes Infect."},{"issue":"8","key":"10.1016\/j.imbio.2023.152348_b0095","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41591-020-0965-6","article-title":"Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"issue":"12","key":"10.1016\/j.imbio.2023.152348_b0100","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3390\/v12121433","article-title":"Dysregulated interferon response underlying severe COVID-19","volume":"12","author":"Lopez","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.imbio.2023.152348_b0105","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13578-020-00519-8","article-title":"ACE2: The Molecular Doorway to SARS-CoV-2","volume":"10","author":"Medina-Enr\u00edquez","year":"2020","journal-title":"Cell Biosci"},{"issue":"6","key":"10.1016\/j.imbio.2023.152348_b0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41577-020-0331-4","article-title":"Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages","volume":"20","author":"Merad","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.imbio.2023.152348_b0115","doi-asserted-by":"crossref","unstructured":"Ong, S.W.X., Fong, S.W., Young, B.E., Chan, Y.H., Lee, B., Amrun, S.N., Chee, R.S.L., Yeo, N.K.W., Tambyah, P., Pada, S. and Tan, S.Y. (2021, June). Persistent symptoms and association with inflammatory cytokine signatures in recovered coronavirus disease 2019 patients. In Open forum infectious diseases (Vol. 8, No. 6, p. ofab156). US: Oxford University Press.","DOI":"10.1093\/ofid\/ofab156"},{"issue":"2","key":"10.1016\/j.imbio.2023.152348_b0120","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41590-021-01113-x","article-title":"Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection","volume":"23","author":"Phetsouphanh","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imbio.2023.152348_b0125","doi-asserted-by":"crossref","unstructured":"Piccioli, P., and Rubartelli, A. (2013, December). The secretion of IL-1\u03b2 and options for release. In Seminars in immunology (Vol. 25, No. 6, pp. 425-429). Academic Press.","DOI":"10.1016\/j.smim.2013.10.007"},{"issue":"7821","key":"10.1016\/j.imbio.2023.152348_b0130","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.imbio.2023.152348_b0140","doi-asserted-by":"crossref","first-page":"100663","DOI":"10.1016\/j.xcrm.2022.100663","article-title":"The IL-1\u03b2, IL-6, and TNF cytokine triad is associated with post-acute sequelae of COVID-19","volume":"3","author":"Schulthei\u00df","year":"2022","journal-title":"Cell Reports. Med."},{"issue":"3","key":"10.1016\/j.imbio.2023.152348_b0145","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.medj.2021.02.001","article-title":"Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6\u20138 months after the infection","volume":"2","author":"Sherina","year":"2021","journal-title":"Med."},{"key":"10.1016\/j.imbio.2023.152348_b0150","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virol.2020.04.011","article-title":"Association of viral load with serum biomakers among COVID-19 cases","volume":"546","author":"Shi","year":"2020","journal-title":"Virology"},{"issue":"19","key":"10.1016\/j.imbio.2023.152348_b0160","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.cell.2021.08.016","article-title":"The interferon landscape along the respiratory tract impacts the severity of COVID-19","volume":"184","author":"Sposito","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.imbio.2023.152348_b0165","doi-asserted-by":"crossref","first-page":"100242","DOI":"10.1016\/j.lanepe.2021.100242","article-title":"Long COVID risk-a signal to address sex hormones and women's health","volume":"11","author":"Stewart","year":"2021","journal-title":"Lancet Regional Health-Europe"},{"issue":"3","key":"10.1016\/j.imbio.2023.152348_b0170","doi-asserted-by":"crossref","first-page":"100040","DOI":"10.1016\/j.xcrm.2020.100040","article-title":"Rapid generation of neutralizing antibody responses in COVID-19 patients","volume":"1","author":"Suthar","year":"2020","journal-title":"Cell Reports Med."},{"issue":"2","key":"10.1016\/j.imbio.2023.152348_b0175","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00408-021-00423-z","article-title":"Post-COVID-19 symptom burden: what is long-COVID and how should we manage it?","volume":"199","author":"Sykes","year":"2021","journal-title":"Lung"},{"key":"10.1016\/j.imbio.2023.152348_b0180","article-title":"Longitudinal immune dynamics of mild COVID-19 define signatures of recovery and persistence","author":"Talla","year":"2021","journal-title":"BioRxiv."},{"issue":"7","key":"10.1016\/j.imbio.2023.152348_b0185","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jiac.2021.03.007","article-title":"Prolonged viral clearance of severe acute respiratory syndrome coronavirus 2 in the older aged population","volume":"27","author":"Ueno","year":"2021","journal-title":"J. Infect. Chemother."},{"issue":"10","key":"10.1016\/j.imbio.2023.152348_b0195","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/23744235.2021.1924397","article-title":"Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments","volume":"53","author":"Yong","year":"2021","journal-title":"Infect. Dis."},{"issue":"1","key":"10.1016\/j.imbio.2023.152348_b0205","first-page":"1","article-title":"Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals","volume":"5","author":"Zhang","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"16","key":"10.1016\/j.imbio.2023.152348_b0210","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/cid\/ciaa344","article-title":"Antibody responses to SARS-CoV-2 in patients with novel coronavirus disease 2019","volume":"71","author":"Zhao","year":"2020","journal-title":"Clin. Infect. Dis."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:53:41Z","timestamp":1759251221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298523000165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0171298523000165"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152348","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of some immunological signatures and their association with COVID-19 in a sample of recovered Iraqi patients","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152348"}}